ロード中...
Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK
Background: Venous thromboembolism (VTE), which includes pulmonary embolism (PE) and deep vein thrombosis (DVT), is the third most common acute cardiovascular disease and represents an important burden for patients and payers. Objective: The aim was to estimate the cost-effectiveness of edoxaban, a...
保存先:
| 出版年: | J Mark Access Health Policy |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Routledge
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6052426/ https://ncbi.nlm.nih.gov/pubmed/30034645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2018.1495974 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|